Trial in progress: A phase 2 basket trial of nanatinostat in combination with valganciclovir in patients with EBV-Positive (EBV+) relapsed/refractory lymphomas (NAVAL-1)

Rituxan (rituximab) - Biogen, Zenyaku Kogyo, Roche

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

Cytovene (ganciclovir) - Roche

nanatinostat (VRx-3996) - Viracta Therap

Young-Rok Do1*; Won Sik Lee2; Jae Hoon Lee3; Dong Won Baek4; Seok-Goo Cho5; Donald Strickland6; Lisa Rojkjaer6

Mar 31, 2023